ICOA
IRD

Investment Centers of America’s Opus Genetics IRD Stock Holding History

Investment Centers of America’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-36
Closed -$2K – 664
2016
Q4 		$2K Hold
36
– – ﹤0.01% 615
2016
Q3 		$4K Hold
36
– – ﹤0.01% 543
2016
Q2 		$5K Buy
36
+15
+71% +$2.1K ﹤0.01% 507
2016
Q1 		$3K Hold
21
– – ﹤0.01% 535
2015
Q4 		$4K Buy
+21
New +$4.47K ﹤0.01% 485

Other funds holding IRD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BMC
Benin Management Corp Wilton, Connecticut $494M AUM 25.95% 1-Year Est. Return

Investment Centers of America's IRD Position: Q1 2017 in Review

Investment Centers of America sold out of Opus Genetics (IRD) in Q1 2017, closing a stake of 36 shares — an estimated $2K sold.

Investment Centers of America first reported a position in IRD in Q4 2015 and held it in 5 quarters. The position peaked at $5K in Q2 2016. 33 funds tracked by Wall St. Rank hold IRD as of Q1 2017.

  • Investment Centers of America reported no remaining Opus Genetics position as of Q1 2017 after selling out during the quarter.
  • Investment Centers of America sold 36 Opus Genetics shares in Q1 2017, an estimated $2K.
  • Investment Centers of America first reported a position in Opus Genetics in Q4 2015 and held it in 5 quarters.
  • Investment Centers of America's Opus Genetics position peaked at $5K in Q2 2016.
  • 33 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2017.

Based on Investment Centers of America's 13F filing for Q1 2017, filed 15 May 2017.